Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands.
<h4>Background</h4>Stroke prevention is the main goal of treating patients with atrial fibrillation (AF). Vitamin-K antagonists (VKAs) present an effective treatment in stroke prevention, however, the risk of bleeding and the requirement for regular coagulation monitoring are limiting th...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Public Library of Science (PLoS)
2014
|
| Subjects: | |
| Online Access: | https://doaj.org/article/66a2246e4ad8431898941e600348e958 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|